What is the long-term trend for Medpace Holdings, Inc.'s allowance for doubtful accounts receivable (current)?

Over 4 years (2021 to 2025), Medpace Holdings, Inc.'s allowance for doubtful accounts receivable (current) has grown at a -35.8% compound annual growth rate (CAGR), from $171K to $29K.

Medpace Holdings, Inc. MEDP Allowance for Doubtful Accounts Receivable (Current)

Allowance for Doubtful Accounts Receivable (Current) at other companies

Labcorp HoldingsLH

——

IQVIAIQV

——

Veeva SystemsVEEV

——

Medline, Inc. MDLN

——

Other financials

Income statement

See full

Revenue$706.6M+26.5%

Operating income$141.5M+24.6%

Net income$123.9M+8.1%

EPS (diluted)$4.28+16.6%

Balance sheet

See full

Cash & equivalents$652.7M+47.9%

Total debt$146.1M-2.8%

Total equity$598.3M+0.8%

Total assets$2.1B+12.2%

Cash flow

See full

Operating cash flow$151.8M+20.6%

CapEx$6.8M-31.8%

Free cash flow$145.0M+25.1%

Valuation

See full

Market cap$13.14B+46.8%

Enterprise value$12.64B+45.9%

P/E28.6×+7.0×

P/S4.9×+0.8×

Profitability

See full

Operating margin21%-0.1pp

Net margin17.2%-2.1pp

FCF margin26.5%+1.5pp

Returns & leverage

See full

Return on equity77.3%+11.4pp

Debt / equity0.2×0.0×

Current ratio0.8×+0.1×

Where this comes from

Reported directly by Medpace Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent.

The official record: Medpace Holdings, Inc.’s 10-Q, filed April 23, 2026, on SEC EDGAR. View the filing →

Ask your AI about Medpace Holdings, Inc.'s allowance for doubtful accounts receivable (current).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Medpace Holdings, Inc.'s allowance for doubtful accounts receivable (current)?: Medpace Holdings, Inc. (MEDP) reported allowance for doubtful accounts receivable (current) of $28K in Q1 2026.
What is the long-term trend for Medpace Holdings, Inc.'s allowance for doubtful accounts receivable (current)?: Over 4 years (2021 to 2025), Medpace Holdings, Inc.'s allowance for doubtful accounts receivable (current) has grown at a -35.8% compound annual growth rate (CAGR), from $171K to $29K.